Form4insider filings, from the source

SEC Form 4 · accession 0001209191-19-001524

Odonate Therapeutics, Inc. · ODT

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner
John G Lemkey
Officer — Chief Operating Officer
Period of report
Dec 31, 2018
Accepted (ET)
Jan 3, 2019 · 8:09 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001717452

Table I — non-derivative securities

SecurityDateCodeSharesPriceA/DOwned afterD/INature of ownership
Common StockDec 31, 2018A70$11.97A936D
Common StockF2holding———12,946,038IBy LP

Table II — derivative securities

SecurityConv. / exercise priceDateCodeSharesA/DExercisableExpiresUnderlyingUnderlying sharesOwned afterD/I
Employee Stock Option (Right to Buy)F3$14.08Dec 31, 2018A60,070A—Dec 31, 2028Common Stock60,07060,070D

Explanation of responses